GAITHERSBURG, Md., May 27, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the management team will present during a fireside chat at the 2021 Jefferies Virtual Healthcare Conference, being held June 1 - 4, 2021.
Details on the Jefferies fireside chat presentation are as follows:
|Title:||2021 Jefferies Virtual Healthcare Conference|
|Presenters:||Vipin Garg, Ph.D., Chief Executive Officer|
|Scot Roberts, Ph.D., Chief Scientific Officer|
|Scott Harris, M.D., Chief Medical Officer|
|Date/Time:||Wednesday, June 2, 2021 at 11:30 am ET|
A webcast link to the fireside chat presentation will be accessible on the Events section of the Altimmune website.
Altimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Our diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID™), anthrax (NasoShield™) and influenza (NasoVAX™); an intranasal immune modulating therapeutic for COVID-19 (T-COVID™); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell™). For more information on Altimmune, please visit www.altimmune.com.
|Investor & Media Contacts:|
|Will Brown||Stacey Jurchison|
|Chief Financial Officer||Sr. Dir, Investor Relations|
|Phone: 240-654-1450||Phone : 410-474-8200|